About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Glenmark Pharmaceuticals Ltd.
BSE Code
532296
ISIN Demat
INE935A01035
Book Value
848.58
NSE Code
GLENMARK
Dividend Yield %
0.16
Market Cap
435232.90
P/E
7.71
EPS
199.94
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
20-Dec-2024
1517.25
1560.00
1517.25
1542.35
9138
14124477
19-Dec-2024
1485.30
1550.80
1485.30
1540.00
7886
12086610
18-Dec-2024
1529.95
1542.00
1510.95
1524.20
9274
14200952
17-Dec-2024
1550.00
1553.80
1506.50
1512.60
13184
20170229
16-Dec-2024
1510.80
1562.00
1501.50
1551.40
13307
20512929
13-Dec-2024
1544.45
1544.45
1447.00
1517.20
52871
78698740
12-Dec-2024
1544.95
1545.00
1527.85
1534.50
298220
457187099
11-Dec-2024
1543.70
1550.00
1524.00
1526.10
11297
17348919
10-Dec-2024
1540.00
1576.75
1530.00
1543.70
41328
64281164
09-Dec-2024
1523.45
1528.00
1506.00
1513.75
14171
21444825
06-Dec-2024
1559.95
1559.95
1521.35
1528.25
11719
17946048
05-Dec-2024
1549.65
1552.00
1513.40
1544.80
12780
19680592
04-Dec-2024
1560.05
1563.70
1543.15
1547.75
6721
10433394
03-Dec-2024
1550.00
1568.10
1540.95
1558.15
10125
15752810
02-Dec-2024
1520.75
1564.00
1520.75
1550.00
11248
17412640
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.